Compare RLJ & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLJ | TNDM |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | United States |
| Employees | 73 | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | N/A | 2013 |
| Metric | RLJ | TNDM |
|---|---|---|
| Price | $8.85 | $14.24 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 19 |
| Target Price | $7.83 | ★ $28.00 |
| AVG Volume (30 Days) | ★ 3.0M | 2.0M |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | ★ 7.26% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,014,736,000.00 |
| Revenue This Year | $2.02 | $8.11 |
| Revenue Next Year | $2.54 | $11.85 |
| P/E Ratio | $188.67 | ★ N/A |
| Revenue Growth | N/A | ★ 7.93 |
| 52 Week Low | $6.54 | $10.00 |
| 52 Week High | $9.00 | $29.65 |
| Indicator | RLJ | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 70.49 | 27.50 |
| Support Level | $7.24 | $13.24 |
| Resistance Level | N/A | $15.75 |
| Average True Range (ATR) | 0.24 | 1.35 |
| MACD | 0.05 | -0.53 |
| Stochastic Oscillator | 88.26 | 2.65 |
RLJ Lodging Trust is a real estate investment trust focused on premium-branded, rooms-oriented, high-margin, focused-service, and compact full-service hotels located within the heart of demand locations. Its hotels are geographically diverse and concentrated in urban markets providing multiple demand generators from business, leisure, and other travelers. Its hotels are under the Marriott, Hilton, and Hyatt brand names. The Hotel is a single reportable segment. Its hotel segment revenues are derived from the operation of hotel properties which includes room revenue by renting hotel rooms, food and beverage revenue from the sale of food and beverages, and other revenue from parking fees, resort fees, gift shop sales, and other guest service fees.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.